Bath & Body Works director awarded 13,284 shares

Bath & Body Works, Inc. director Sarah E. Nash received an annual equity award in the form of restricted stock units.

Rhea-AI Filing Summary

Bath & Body Works, Inc. director Sarah E. Nash received an annual equity award in the form of restricted stock units. On June 11, 2026, she was granted 13,284 shares of common stock at no cash cost as director compensation. Following this grant, her direct holdings increased to 298,894.77 shares of common stock, which include 88.77 shares acquired through the company’s Dividend Reinvestment Plan.

Insider Trade Summary

Grant/Award: 13,284 shares

Grant/Award 1 txn

Insider Nash Sarah E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.50 par value	13,284	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.50 par value — 298,894.77 shares (Direct)

Footnotes (2)

1. F1. Annual award of restricted stock units to independent non-employee directors.
2. F2. Total includes 88.77 shares acquired pursuant to the Issuer's Dividend Reinvestment Plan.

Key Figures

Director grant size: 13,284 shares Total holdings after grant: 298,894.77 shares Dividend Reinvestment Plan shares: 88.77 shares +2 more

5 metrics

Director grant size 13,284 shares Annual restricted stock unit award on June 11, 2026

Total holdings after grant 298,894.77 shares Director Sarah E. Nash direct ownership after transaction

Dividend Reinvestment Plan shares 88.77 shares Portion of Nash’s total shares acquired via DRIP

Par value per share $0.50 par value Common Stock of Bath & Body Works, Inc.

Transaction date June 11, 2026 Date of restricted stock unit grant

Key Terms

restricted stock units, Dividend Reinvestment Plan, independent non-employee directors, Common Stock, $0.50 par value

4 terms

restricted stock units financial

"Annual award of restricted stock units to independent non-employee directors."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Dividend Reinvestment Plan financial

"Total includes 88.77 shares acquired pursuant to the Issuer's Dividend Reinvestment Plan."

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

independent non-employee directors financial

"Annual award of restricted stock units to independent non-employee directors."

Common Stock, $0.50 par value financial

"Common Stock, $0.50 par value"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bath & Body Works (BBWI) director Sarah Nash report on this Form 4?

Director Sarah E. Nash reported receiving an annual equity award of 13,284 shares of Bath & Body Works common stock. The grant was compensation in restricted stock units, not an open-market purchase, and increased her directly held position in the company.

How many Bath & Body Works (BBWI) shares did Sarah Nash receive in this grant?

Sarah E. Nash received 13,284 shares of Bath & Body Works common stock as a grant. The award represents an annual grant of restricted stock units provided to independent non-employee directors serving on the company’s board of directors.

What is Sarah Nash’s total Bath & Body Works (BBWI) ownership after the grant?

After the June 11, 2026 grant, Sarah E. Nash directly holds 298,894.77 shares of Bath & Body Works common stock. This total includes 88.77 shares accumulated through participation in the company’s Dividend Reinvestment Plan over time.

Was the Bath & Body Works (BBWI) share grant to Sarah Nash an open-market purchase?

No, the reported transaction was not an open-market purchase. It was a grant of restricted stock units awarded at no cash cost as annual compensation for Nash’s service as an independent non-employee director on the Bath & Body Works board.

What role does Sarah Nash hold at Bath & Body Works (BBWI)?

Sarah E. Nash is identified as a director of Bath & Body Works, Inc. The filing specifies she is an independent non-employee director, receiving an annual restricted stock unit award as part of the company’s standard board compensation program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nash Sarah E

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OHIO 43230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	06/11/2026		A		13,284(1)	A	$0.0000	298,894.77(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual award of restricted stock units to independent non-employee directors.

2. Total includes 88.77 shares acquired pursuant to the Issuer's Dividend Reinvestment Plan.

	Robert J. Tannous, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)